Live feed06:30:00·955dPRReleasevia QuantisnowPhotocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary EndpointByQuantisnow·Wall Street's wire, on your screen.PHO· Invesco Water Resources ETF